Moreover, CD226 seems to correlate better with strong immune activation in liver metastasis than in primary CRC, despite the known immunosuppressive tumor microenvironment (TME) in the liver and the inflammatory context in primary CRC. The gene discussed is CD226; the disease is neoplasm.